Children with diabetic ketoacidosis in the hospital
Part of Hormones & metabolism clinical trials.
This study looks at children age 1 to 16 who are in the hospital for diabetic ketoacidosis (DKA). It aims to understand how these children are doing and what treatments might work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 1 and 16 years old
- Child is hospitalized with diabetic ketoacidosis (a serious complication of diabetes)
- Child does not have other hormone problems like thyroid or pituitary disease
- Child does not have severe liver or kidney disease
- Child has no history of cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at signs of acute organ injury in children newly diagnosed with type 1 diabetes. It aims to understand how the body reacts to diabetes and its treatment, which could help improve care for kids like yours.
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
This trial tests if not eating (fasting) during standard treatment for diabetic ketoacidosis can help patients recover faster or better. It compares the usual treatment to the same treatment without food intake.
This trial tests if an IV medicine called arginine hydrochloride can help manage diabetic ketoacidosis (DKA) in people with type 2 diabetes. It's for those who come to the ER with very high blood sugar and ketones.
This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.
This study looks at how diabetes and related blood-sugar issues affect the health of people with chronic kidney disease who are admitted to the hospital. It aims to find ways to improve care for this group.
Hear when a new Diabetic Ketoacidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.